Singapore markets closed

BioCryst Pharmaceuticals, Inc. (BCRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
15.13-0.32 (-2.07%)
At close: 4:00PM EDT
15.20 +0.07 (+0.46%)
After hours: 07:50PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close15.45
Bid15.15 x 800
Ask15.32 x 4000
Day's range15.12 - 15.53
52-week range3.46 - 18.48
Avg. volume2,707,104
Market cap2.704B
Beta (5Y monthly)2.58
PE ratio (TTM)N/A
EPS (TTM)-1.21
Earnings date03 Nov 2021 - 08 Nov 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est21.27
  • Motley Fool

    2 Super-Charged Growth Stocks to Buy Now

    Growth stocks can be a thing of beauty. The trick, if you will, is to suss out growth stocks that won't rot on the vine, so to speak. While both of these biotech stocks have more than doubled in value in the past three years, I believe each of these healthcare equities still has a lot of room to run in 2022 and beyond.

  • Motley Fool

    3 Biotech Stocks Wall Street Thinks Could Rise 44% or Better

    September's been a lousy month for biotech stocks with the Nasdaq Biotechnology Index down around 5.7% since the end of August. Rising interest rates are the main cause for concern, but that isn't a good reason to lose faith in this particular industry. You could sit around feeling sad about the September sell-off, or you could take advantage of some bargain stock opportunities.

  • Motley Fool

    2 Soaring Biotech Stocks With More Fuel in the Tank

    BioCryst Pharmaceuticals discovers, develops, and markets novel small-molecule drugs to treat rare diseases. BioCryst already has a growing revenue source in Orladeyo. BioCryst stock has been soaring in response to Orladeyo's successful launch.